I bought a few options this morning.With the shares at 20c and the options at 4c I am hopeful even if there is 25c to pay to exercise the options by 2016.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%